For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Build Your Order Apply for Wholesale
Build Your Order Products For Clinics For Pharmacies For Brands Quality Wholesale Resources About Contact Apply for Wholesale
Product sourcing reference

AOD-9604

AOD-9604 is a modified fragment of the growth hormone C-terminus. Review its regulatory status and the evidence behind fat-metabolism claims before requesting it.

Reference variants

Add AOD-9604 to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

  • 5mgVial · confirm physical formCAS 386264-39-7
    $17.25/vialCloseout estimate Regular $34.50. Subject to confirmation; not a stock promise.
    vials, packs of 10
  • 10mgVial · confirm physical formCAS 386264-39-7
    $69.00/vial$55.20/vial at 1,000+ vials of this item
    vials, packs of 10

Review your order request · Compare the full catalog

Confirm the exact substance

AOD-9604 corresponds to residues 177-191 of human growth hormone with an added N-terminal tyrosine. It is a different molecule from HGH Fragment 176-191, although the two are often marketed together.

What the review will ask

Weight-related claims for AOD-9604 did not translate into an approved product. Ask whether the material is intended for a permitted use before requesting terms.

  • State the facility type, destination state and intended transaction. Do not send patient information.
  • Expect product- and lot-specific documentation to be requested before any material is accepted.
  • A listed price is a reference estimate. Availability, labeling, shipping and terms are confirmed in writing only after review.

Purchasing questions

Is AOD-9604 the same as HGH Fragment 176-191?

No. They are closely related fragments of growth hormone but differ in sequence. Do not treat their names as interchangeable on a request.

Compare exact fragments rather than marketing labels

FDA identifies safety information gaps and characterization concerns for AOD-9604. A proposal must distinguish it from an HGH fragment reference rather than assuming related names identify interchangeable material.

Documentation to request

Request the complete sequence, modification and salt information. Match the supporting studies and analytical records to that identity.

Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Longevity clinic documentation questions. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. This reference is not medical or legal advice and does not establish a lawful supply route.

Discuss sourcing requirements
Call Apply for Wholesale